Not Treating – A Neglected Option

Medicine has a reputation for being a “do something” profession. You show up with pain, fear, a weird bump, or a test result that looks like it has
opinionsand the usual expectation is action: a prescription, a procedure, a scan, a plan with at least three follow-up visits and a coupon for an
expensive water bottle.

But there’s a quieter, often smarter choice that doesn’t get enough respect: not treatingalso known as watchful waiting,
active surveillance, conservative management, or, in plain English, “Let’s not rush into a thing we can’t un-do.”

“Not treating” isn’t neglect. It’s not ignoring symptoms. It’s a deliberate strategy that uses time, monitoring, and shared decision-making to avoid
unnecessary harmwhile still keeping you safe. In a healthcare system where more can sometimes mean more side effects, more anxiety, more
bills, not treating can be the most protective move on the board.

What “Not Treating” Actually Means (and What It Definitely Doesn’t)

Let’s clear up the biggest misunderstanding: not treating is still a plan. It’s a plan that chooses observation and symptom support
now, with clear rules for when to escalate later.

Not treating usually includes:

• Monitoring: watching symptoms, repeating specific exams or tests on a schedule, and tracking changes.
• Supportive care: comfort measures (like rest, fluids, pain relief, physical therapy, or lifestyle steps).
• Safety netting: a clear “If X happens, call immediately” list.
• Reassessment: a planned check-in datebecause “we’ll see” is only helpful if someone is actually looking.

Not treating is not:

• Dismissal: “It’s all in your head” is not a medical strategy.
• Delay forever: the point is to avoid unnecessary treatment, not to miss necessary treatment.
• No responsibility: clinicians still own the follow-up plan, and patients still deserve clarity.

In other words, “not treating” is less like doing nothing and more like choosing a different tool: patiencewith guardrails.

Why Not Treating Feels So Uncomfortable

If not treating can be safe and evidence-based, why is it neglected? Because it fights three powerful forces: psychology, culture, and fear.

1) Our brains hate uncertainty

A pill feels like progress. A test result feels like “information,” even when it doesn’t change what we do next. Waiting feels like vulnerability.
Humans are wired to prefer actionespecially when we’re anxious.

2) “Doing more” looks like caring more

Patients often worry that “no treatment” means they aren’t being taken seriously. Clinicians may worry the same thing: that reassurance won’t feel
adequate, or that they’ll look careless. Ironically, the most careful choice can look passive from the outside.

3) Fear of missing something is real

Nobody wants to overlook a serious condition. That fear can push decisions toward “just in case” careextra imaging, extra antibiotics, extra
interventions. The problem is that “just in case” can come with real downsides: false alarms, invasive follow-ups, side effects, and long-term harm.

The goal isn’t to become anti-treatment. It’s to become pro-appropriate treatment.

When Not Treating Is the Best Medicine

Not treating tends to be most appropriate when (1) the condition is likely to improve on its own, (2) early treatment doesn’t meaningfully improve
outcomes, or (3) the harms of immediate treatment are likely to outweigh the benefits.

Scenario A: Self-limited illnesses (where time is the cure)

Many common illnesses improve without targeted treatmentespecially viral infections. Supportive care may be the main strategy while the immune system
does its job. Overusing medications like antibiotics in situations where they aren’t helpful can cause side effects and contribute to antibiotic
resistance.

A practical example: mild ear infections in children. Public health guidance describes “watchful waiting” for a short period in certain
mild cases, giving the body time to improve before starting antibioticswhile managing pain and fever and watching for worsening symptoms.

Scenario B: “Watchful waiting” for mild conditions with good safety nets

Some conditions have “watch-and-wait” built into modern care because the evidence shows many cases resolveor don’t need aggressive treatment right
away. What matters is selecting the right patients and setting clear boundaries.

This approach can reduce unnecessary medication use and avoid side effects, while still treating promptly when symptoms persist or escalate.
The key is that watchful waiting is time-limited and structured, not vague.

Scenario C: Avoiding unnecessary imaging and “incidentalomas”

Imaging can be lifesaving when it’s used for the right reasons. But early or unnecessary imaging can also uncover incidental findingstiny “something”
spots that look suspicious but are harmless. Those findings can trigger a chain reaction: more scans, biopsies, anxiety, and sometimes procedures that
never improve outcomes.

A classic example is uncomplicated low back pain. Many clinical recommendations discourage early imaging in the absence of red flags,
because it usually doesn’t change management and can lead to unnecessary follow-up and cost. Conservative caremovement, physical therapy, heat, and
timeoften wins this race.

Scenario D: Low-risk cancers where “monitoring first” protects quality of life

This is where not treating stops being the “soft option” and becomes a highly technical plan.

Active surveillance and watchful waiting are established strategies in certain cancers, especially where disease can be
slow-growing and treatment side effects can be significant. The intent is to avoid or delay interventions like surgery or radiation unless the disease
shows signs of progression.

In prostate cancer, for instance, active surveillance typically involves scheduled monitoring (such as PSA tests and repeat evaluation). Watchful
waiting may be less intensive and more symptom-driven in selected cases. The shared theme is that immediate treatment isn’t automatically the safest
optionsometimes it’s the most disruptive.

Similar conversations exist around small thyroid cancers and thyroid nodules, where overdiagnosis and overtreatment are recognized risks. “Not treating
right now” can mean protecting someone from lifelong hormone replacement, surgical risks, and the emotional aftermath of a label that may never have
harmed them.

Scenario E: Screening decisions where the “best choice” depends on your values

Some preventive screenings are straightforward. Others involve trade-offs: benefits for some people, harms for others, and a lot of “it depends.”
That’s where shared decision-making matters most.

In thyroid cancer screening for asymptomatic adults, for example, major preventive guidance recommends against routine screening because harms like
overdiagnosis and unnecessary treatment can outweigh benefits in the general population. That’s a reminder that sometimes not doing the test is
the more protective choice.

The Hidden Costs of Overtreatment (It’s Not Just Money)

Overtreatment isn’t a moral failure; it’s often a well-intended response to uncertainty. But it can still cause harm. The most common “costs” show up
in four buckets:

1) Physical harms

Every medication has side effects. Every procedure has risks. Even “simple” interventions can create complications that become new problems.
When treatment isn’t necessary, those risks become harder to justify.

2) Psychological harms

False positives and incidental findings can create months of anxiety, repeat testing, and a sense that your body is a ticking time bomb.
Sometimes the emotional toll of “maybe” is heavier than the original symptom.

3) Cascade effects

One unnecessary test can lead to another. A borderline result becomes a referral. The referral becomes a biopsy. The biopsy becomes a complication.
This is how people end up harmed by healthcare that was supposed to be “just checking.”

4) Public health harms

Antibiotics are the clearest example. Using them when they aren’t needed can contribute to antimicrobial resistancemeaning the drugs work less well
when we truly need them. That’s not abstract; it affects future infections, community health, and the effectiveness of modern medicine.

How Clinicians Make “Not Treating” Safer: The Three-Part Framework

Good “not treating” is not luck. It’s a repeatable method. Most evidence-based conservative care includes three elements.

1) Risk stratification: Who is safe to observe?

This is the screening step. Clinicians look for severity, duration, age-related risks, medical history, immune status, and “red flags” that suggest
a serious underlying condition. If red flags exist, observation may be inappropriate.

2) Time as a diagnostic tool

Many conditions declare themselves over time. If symptoms steadily improve, that’s reassuring. If they worsen, change character, or fail to improve on
schedule, that’s useful informationand it can justify more testing or treatment.

3) Shared decision-making: Choosing the plan that matches your life

Shared decision-making is the conversation where evidence meets values. Some patients prioritize avoiding side effects. Others prioritize acting quickly
to reduce uncertainty. Neither is “wrong.” The goal is to be honest about trade-offs so people can choose knowingly.

How to Talk to Your Clinician About Not Treating (Without Sounding Like You Read One Article and Now You’re a Professor)

If you want to consider watchful waiting or active surveillance, you don’t have to “argue” for it. You can ask for clarity. Try these questions:

• “What are we trying to prevent or improve by treating right now?”
• “If we don’t treat today, what’s the realistic downside?”
• “What symptoms or changes would mean we should act sooner?”
• “What’s the follow-up planand when do we reassess?”
• “What are the side effects or long-term consequences of treatment?”
• “Are there conservative steps I can do in the meantime?”

You’re not refusing care. You’re designing it.

A “Not Treating” Checklist You Can Actually Use

If you’re considering not treating, it helps to turn it into a concrete agreement. Here’s what a solid plan typically includes:

Write down:

• The working diagnosis (even if it’s “likely viral” or “uncomplicated”).
• What you’re doing for symptoms (pain relief, hydration, activity, sleep, physical therapy, etc.).
• How long you’ll observe before reconsidering (e.g., 48–72 hours, 2 weeks, 3 monthsdepending on the condition).
• Red flags that trigger immediate reassessment.
• Your follow-up appointment or check-in method (portal message, phone call, in-person visit).

If your plan doesn’t include follow-up, it’s not watchful waiting. It’s just waiting.

The Big Ethical Point: Sometimes Less Care Is More Care

“Not treating” can feel like withholding help, but it can be the opposite: it’s protecting people from interventions they don’t need. In ethical terms,
it honors two important principles:

• Nonmaleficence: avoid causing harm when the benefit is uncertain or small.
• Autonomy: help people choose based on what matters to themnot just what’s available.

It also respects real life. Some treatments trade one problem for another (pain for side effects, worry for complications). A careful “monitor first”
strategy can preserve quality of life while keeping medical options available if the situation changes.

Conclusion: “Not Treating” Isn’t Doing NothingIt’s Choosing Wisely

Not treating is a neglected option because it doesn’t look dramatic. There’s no pharmacy bag. No before-and-after photo. No heroic montage. But for many
conditionsespecially mild, self-limited problems; uncomplicated pain; and certain low-risk cancersthoughtful observation with a safety plan
can be the most evidence-based move you can make.

The best healthcare isn’t the most aggressive. It’s the most appropriate. And sometimes the best prescription is:
“Let’s watch this closely, support you well, and treat only if we truly need to.”

Experiences: Life in the In-Between ()

People rarely tell stories that start with, “So I chose conservative management and then… nothing happened.” But that’s often the pointand it can be a
surprisingly emotional experience.

Experience #1: The parent who wanted antibiotics “just to be safe.”
A common scenario goes like this: a child has ear pain, a fever, and a miserable look that could melt steel. A parent shows up ready for a prescription,
because doing something feels like love. When the clinician suggests watchful waiting (with pain control and a strict follow-up plan), the parent may
feel dismissed at firstuntil the plan is explained clearly: what improvement should look like, what “worse” looks like, and exactly when to call.
Many parents later describe a shift from “I felt ignored” to “I felt empowered,” because they weren’t sent home empty-handedthey were sent home with a
strategy and permission to escalate if needed.

Experience #2: The back pain spiral that a scan almost worsened.
Someone strains their back moving a couch (the couch survives, naturally). The pain is sharp, sleep is bad, and anxiety is loud. The temptation is to
demand imaging immediately for reassurance. But many people who follow a conservative plangentle movement, heat, time, and physical therapydescribe a
surprising discovery: their fear improved before their pain did. By the time a scan would have happened, the pain is already trending down. They also
avoid the “incidental finding” roulettethose scary-sounding but harmless MRI notes that can turn a simple strain into a months-long medical saga.

Experience #3: Active surveillance and the art of living with a “maybe.”
For people monitoring a low-risk cancer, the emotional workload can be heavier. There’s relief in avoiding immediate side effects, but also a background
hum: “What if it changes?” Many describe a pattern: anxiety spikes before checkups, then fades when results are stable. Over time, routines helpkeeping
a calendar, having a consistent clinician, and knowing what would trigger treatment. The people who do best often say the same thing: they didn’t choose
denial. They chose structured attention.

Experience #4: The weird pride of making a calm, informed choice.
Once people realize not treating is an active decisionnot a lack of carethey often feel a quiet confidence. It’s the feeling of not being pushed
around by fear, marketing, or the idea that “more medicine” automatically equals “better medicine.” The takeaway most people share is simple:
a good plan isn’t measured by how intense it isit’s measured by whether it fits the evidence and the person living inside the body.